Hemofiltration: Determinants of drug loss and concentration

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Ultrafiltration has proven to be an effective method of reducing post- cardiopulmonary bypass edema and the inflammatory response associated with activation of the complement cascade. Recently, a modified ultrafiltration process has been developed which allows further hemoconcentration after weaning from bypass. Both of these procedures can have an effect upon the concentrations of many of the pharmaceutical agents being used either pre- or perioperatively. Based upon work done by other investigators in the field of dialysis, we have developed sieving coefficients for many cardiovascular drugs in order to provide an estimation of their loss during extended periods of hemofiltration. Our study utilized the pharmacological and physical characteristics for volume of distribution and protein binding to determine the movement of drugs through a hemofilter. Our results demonstrated that concentrations of certain drugs used during open heart surgery may be significantly increased or decreased with the use of hemofiltration techniques.

Original languageEnglish (US)
Pages (from-to)158-163
Number of pages6
JournalJournal of Extra-Corporeal Technology
Volume27
Issue number3
StatePublished - 1995

Fingerprint

Hemofiltration
Ultrafiltration
Pharmaceutical Preparations
Cardiovascular Agents
Complement Activation
Cardiopulmonary Bypass
Protein Binding
Thoracic Surgery
Dialysis
Edema
Research Personnel
Pharmacology

Keywords

  • hemoconcentration
  • protein binding
  • sieving coefficient
  • ultrafiltration

ASJC Scopus subject areas

  • Medicine (miscellaneous)

Cite this

Hemofiltration : Determinants of drug loss and concentration. / Clar, A.; Larson, Douglas F.

In: Journal of Extra-Corporeal Technology, Vol. 27, No. 3, 1995, p. 158-163.

Research output: Contribution to journalArticle

@article{585697e72ee54408805e6530e553928e,
title = "Hemofiltration: Determinants of drug loss and concentration",
abstract = "Ultrafiltration has proven to be an effective method of reducing post- cardiopulmonary bypass edema and the inflammatory response associated with activation of the complement cascade. Recently, a modified ultrafiltration process has been developed which allows further hemoconcentration after weaning from bypass. Both of these procedures can have an effect upon the concentrations of many of the pharmaceutical agents being used either pre- or perioperatively. Based upon work done by other investigators in the field of dialysis, we have developed sieving coefficients for many cardiovascular drugs in order to provide an estimation of their loss during extended periods of hemofiltration. Our study utilized the pharmacological and physical characteristics for volume of distribution and protein binding to determine the movement of drugs through a hemofilter. Our results demonstrated that concentrations of certain drugs used during open heart surgery may be significantly increased or decreased with the use of hemofiltration techniques.",
keywords = "hemoconcentration, protein binding, sieving coefficient, ultrafiltration",
author = "A. Clar and Larson, {Douglas F}",
year = "1995",
language = "English (US)",
volume = "27",
pages = "158--163",
journal = "Journal of Extra-Corporeal Technology",
issn = "0022-1058",
publisher = "American Society of Extra-Corporeal Technology",
number = "3",

}

TY - JOUR

T1 - Hemofiltration

T2 - Determinants of drug loss and concentration

AU - Clar, A.

AU - Larson, Douglas F

PY - 1995

Y1 - 1995

N2 - Ultrafiltration has proven to be an effective method of reducing post- cardiopulmonary bypass edema and the inflammatory response associated with activation of the complement cascade. Recently, a modified ultrafiltration process has been developed which allows further hemoconcentration after weaning from bypass. Both of these procedures can have an effect upon the concentrations of many of the pharmaceutical agents being used either pre- or perioperatively. Based upon work done by other investigators in the field of dialysis, we have developed sieving coefficients for many cardiovascular drugs in order to provide an estimation of their loss during extended periods of hemofiltration. Our study utilized the pharmacological and physical characteristics for volume of distribution and protein binding to determine the movement of drugs through a hemofilter. Our results demonstrated that concentrations of certain drugs used during open heart surgery may be significantly increased or decreased with the use of hemofiltration techniques.

AB - Ultrafiltration has proven to be an effective method of reducing post- cardiopulmonary bypass edema and the inflammatory response associated with activation of the complement cascade. Recently, a modified ultrafiltration process has been developed which allows further hemoconcentration after weaning from bypass. Both of these procedures can have an effect upon the concentrations of many of the pharmaceutical agents being used either pre- or perioperatively. Based upon work done by other investigators in the field of dialysis, we have developed sieving coefficients for many cardiovascular drugs in order to provide an estimation of their loss during extended periods of hemofiltration. Our study utilized the pharmacological and physical characteristics for volume of distribution and protein binding to determine the movement of drugs through a hemofilter. Our results demonstrated that concentrations of certain drugs used during open heart surgery may be significantly increased or decreased with the use of hemofiltration techniques.

KW - hemoconcentration

KW - protein binding

KW - sieving coefficient

KW - ultrafiltration

UR - http://www.scopus.com/inward/record.url?scp=0029101369&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029101369&partnerID=8YFLogxK

M3 - Article

C2 - 10155361

AN - SCOPUS:0029101369

VL - 27

SP - 158

EP - 163

JO - Journal of Extra-Corporeal Technology

JF - Journal of Extra-Corporeal Technology

SN - 0022-1058

IS - 3

ER -